Page last updated: 2024-09-03

y 27632 and alsterpaullone

y 27632 has been researched along with alsterpaullone in 3 studies

Compound Research Comparison

Studies
(y 27632)
Trials
(y 27632)
Recent Studies (post-2010)
(y 27632)
Studies
(alsterpaullone)
Trials
(alsterpaullone)
Recent Studies (post-2010) (alsterpaullone)
1,924389180031

Protein Interaction Comparison

ProteinTaxonomyy 27632 (IC50)alsterpaullone (IC50)
Chain A, Glycogen Synthase Kinase-3 BetaHomo sapiens (human)0.004
Chain B, Glycogen Synthase Kinase-3 BetaHomo sapiens (human)0.004
Chain A, Glycogen Synthase Kinase-3 BetaHomo sapiens (human)0.004
G2/mitotic-specific cyclin-B2Homo sapiens (human)0.035
Cyclin-dependent kinase 1Homo sapiens (human)0.0321
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 21.5
G2/mitotic-specific cyclin-B1Homo sapiens (human)0.035
G2/mitotic-specific cyclin-BMarthasterias glacialis (spiny starfish)0.0263
Glycogen synthase kinase-3 betaRattus norvegicus (Norway rat)0.0263
Cyclin-A2Homo sapiens (human)0.015
Cyclin-dependent kinase 2Homo sapiens (human)0.015
Glycogen synthase kinase-3 alphaHomo sapiens (human)0.0043
Glycogen synthase kinase-3 betaHomo sapiens (human)0.0105
Cyclin-dependent-like kinase 5 Homo sapiens (human)0.0608
Cyclin-dependent kinase 5 activator 1Homo sapiens (human)0.0815
G2/mitotic-specific cyclin-B3Homo sapiens (human)0.035
Cyclin-dependent kinase 1Oryzias latipes (Japanese medaka)0.0263

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alessi, DR; Arthur, JS; Bain, J; Cohen, P; Elliott, M; Hastie, CJ; Klevernic, I; McLauchlan, H; Plater, L; Shpiro, N1
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M1
Augustin, M; Davies, SP; Gao, Y; Harvey, KJ; Kovelman, R; Patel, UA; Woodward, A1

Other Studies

3 other study(ies) available for y 27632 and alsterpaullone

ArticleYear
The selectivity of protein kinase inhibitors: a further update.
    The Biochemical journal, 2007, Dec-15, Volume: 408, Issue:3

    Topics: Amino Acid Sequence; Animals; Cell Line; Drug Design; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Recombinant Proteins; Spodoptera

2007
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

    Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
    The Biochemical journal, 2013, Apr-15, Volume: 451, Issue:2

    Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase

2013